The Statement of Licensing Status (SLS) attests a specified therapeutic product has been registered for use in Singapore. It is usually intended to facilitate the screening and preparation of product information by importing agents when considering bids made in response to an international tender.
The SLS provides details pertaining to the therapeutic product such as:
- Dosage form
- Product registration number
It is issued in the format as recommended by the World Health Organisation, and will expire 24 months from the date of issuance. The SLS cannot be renewed or re-issued, and upon expiry, a new application must be submitted, if required.
The SLS will be transmitted to the requesting party through the applicant.
You will need the following supporting documents to complete your application:
- Latest local sales invoice, if applicable.
- Other supporting documents, if applicable.
Fees and turnaround time
Refer to therapeutic product fees and turnaround time for more information.
How to apply
Submit your application through PRISM. Ensure you have the following before you access the e-service:
If you encounter technical issues, e-mail the HSA helpdesk or call 6776 0168 (from 7.00 am to midnight daily).
Refer to our guide on New Application for Statement of Licensing Status881 KB
for more details when making an application.